Instead of sense the Braille on the guidelines of his fingertips, the patient could start to see the patterns we projected and read specific letters in under another with up to 89 % accuracy. The experts tested both specific letters and complete phrases as high as four letters. The individual could identify every one of them after just half of a second. The patient’s accuracy on phrases was as high as 80 %. Based on the extensive research, the study’s results are particularly interesting because they indicate a good way to significantly improve reading capability in people who have Argus II implants: these devices could possibly be programmed with a letter-recognition software that instantly converts letters to their Braille equivalents, and tasks the Braille onto the patient’s eye instead..Recently, however, scientists have found that not all transcribed RNA molecules become translated into proteins. In fact, studies have shown that huge portions of the genome are transcribed into RNA that serve tasks other than working as blueprints for proteins. In 2010 2010, the Shiekhattar laboratory first published the discovery of the ncRNA enhancer molecules in the journal Cell :46-58), and theorized on the function as ‘enhancers’ of gene expression. Since that time, laboratories around the world have linked and released ncRNAs not merely to transcriptional enhancers but also to certain illnesses, including some cancers. Related StoriesCHOP researchers delay symptoms, prolong lifespan in animal model of Batten diseaseImproved gene therapy treatment displays promise in mice with cystic fibrosisApoE4-carrying males with Alzheimer's disease vulnerable to brain bleeds To find how such enhancer-like RNAs function, the Shiekhatter laboratory deleted candidate molecules with known roles in activating gene expression, and assessed if they were linked to RNA-dependent activation.